Notice: This company has been marked as potentially delisted and may not be actively trading. Aptinyx (APTX) News Today Add Compare Share Share Headlines Stock Analysis All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Aptinyx Inc Com (OTC:APTX) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comApple Watch X: All the Rumors So FarAugust 25, 2024 | macrumors.comTentarix Biotherapeutics Announces the Appointment of Andrew D. Kidd, MD, CFA, as CEOApril 23, 2024 | businesswire.comNew Leaf Venture Management III, L.L.C.'s Net WorthMarch 12, 2024 | benzinga.comPatrick J Heron's Net WorthFebruary 9, 2024 | benzinga.comBest Noise-Canceling Headphones for 2024January 13, 2024 | cnet.comAptinyx Inc APTXDecember 17, 2023 | morningstar.comNorth American Morning Briefing: Concerns About -2-September 7, 2023 | morningstar.comHere's Why Aptinyx Inc. (APTX) Is a Great 'Buy the Bottom' Stock NowMarch 30, 2023 | finance.yahoo.comAptinyx Reports Results from Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies and Provides Pipeline and Corporate UpdateFebruary 27, 2023 | finance.yahoo.comTrading was temporarily halted for "APTX" at 04:02 PM with a stated reason of "News pending."February 27, 2023 | marketbeat.comAptinyx to Present at the SVB Securities Global Biopharma ConferenceJanuary 31, 2023 | finance.yahoo.comAptinyx Inc. (APTX) Stock Historical Prices & Data - Yahoo FinanceJanuary 16, 2023 | ca.finance.yahoo.comAptinyx (NASDAQ: APTX)January 5, 2023 | fool.comAptinyx Inc. (NASDAQ:APTX) Q3 2022 Earnings Call TranscriptDecember 30, 2022 | insidermonkey.comH.C. Wainwright Keeps Their Buy Rating on Aptinyx (APTX)December 12, 2022 | markets.businessinsider.comAptinyx Reports Third Quarter 2022 Financial Results and Recent HighlightsNovember 8, 2022 | finance.yahoo.comAptinyx Inc. (NASDAQ: APTX)October 30, 2022 | fool.comAptinyx to Report Third Quarter 2022 Financial Results on Tuesday, November 8, 2022October 18, 2022 | finance.yahoo.comAPTX.OQ - Aptinyx Inc | Stock Price & Latest News | ReutersOctober 2, 2022 | reuters.comAptinyx Inc. (APTX)September 24, 2022 | finance.yahoo.comHopeful week for insiders who might be regretting buying US$567k of Aptinyx Inc. (NASDAQ:APTX) stock earlier this year - NasdaqSeptember 12, 2022 | nasdaq.comHC Wainwright Adjusts Price Target on Aptinyx to $1 From $2, Reiterates Buy Rating - Marketscreener.comAugust 26, 2022 | marketscreener.comAptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson's Disease and Dementia with Lewy Bodies - Business WireAugust 25, 2022 | businesswire.comAptinyx Completes Enrollment in Phase 2 Study of NYX-458 in Cognitive Impairment Associated with Parkinson’s Disease and Dementia with Lewy BodiesAugust 25, 2022 | finance.yahoo.comBullish Aptinyx Inc. (NASDAQ:APTX) investors are yet to receive a pay off on their US$567k betAugust 22, 2022 | finance.yahoo.comBiotech Stock Roundup: GILD's Drug News, NVAX & MRNA COVID-19 Vaccine Updates - NasdaqAugust 19, 2022 | nasdaq.comNorth American Morning Briefing: Investors Seek -2- - MorningstarAugust 17, 2022 | morningstar.comWhat 4 Analyst Ratings Have To Say About AptinyxAugust 16, 2022 | markets.businessinsider.comTruist Downgrades Aptinyx to Hold From Buy - Marketscreener.comAugust 15, 2022 | marketscreener.comRecap Of Friday’s Biotech Catalysts - End Of the Day Summary - BenzingaAugust 12, 2022 | benzinga.comAptinyx: Fibromyalgia-Pain Drug Trial Misses Endpoints - MarketWatchAugust 12, 2022 | marketwatch.comAptinyx's Chronic Pain Candidate Fails To Top Placebo In Mid-Stage StudyAugust 12, 2022 | finance.yahoo.comAptinyx Reports Results from Phase 2b Study of NYX-2925 in Fibromyalgia - Business WireAugust 12, 2022 | businesswire.comAptinyx Reports Results from Phase 2b Study of NYX-2925 in FibromyalgiaAugust 12, 2022 | finance.yahoo.comTrading was temporarily halted for "APTX" at 07:08 AM with a stated reason of "News pending."August 12, 2022 | marketbeat.comAptinyx Inc. (APTX) Q2 2022 Earnings Call Transcript - The Motley FoolAugust 6, 2022 | fool.comAptinyx Inc. (APTX) Q2 2022 Earnings Call TranscriptAugust 6, 2022 | fool.comAptinyx Reports Second Quarter 2022 Financial Results and Recent Highlights - Yahoo FinanceAugust 5, 2022 | finance.yahoo.comAptinyx GAAP EPS of -$0.26 beats by $0.02 (NASDAQ:APTX) - Seeking AlphaAugust 4, 2022 | seekingalpha.comAptinyx Reports Second Quarter 2022 Financial Results and Recent Highlights - Business WireAugust 4, 2022 | businesswire.comAptinyx to Report Second Quart - GuruFocus.comJuly 16, 2022 | gurufocus.comAptinyx to Report Second Quarter 2022 Financial Results on Thursday, August 4, 2022July 15, 2022 | finance.yahoo.comU.S. Silica (SLCA) Wraps Up $100 Million Loan Repurchase - NasdaqJuly 13, 2022 | nasdaq.comTFII vs. CHRW: Which Stock Should Value Investors Buy Now? - NasdaqJuly 13, 2022 | nasdaq.comAll You Need to Know About Aptinyx Inc. (APTX) Rating Upgrade to Buy - NasdaqJuly 13, 2022 | nasdaq.comPhilips (PHG) Expands AI Portfolio With SmartSpeed Solution - NasdaqJuly 13, 2022 | nasdaq.comAmerica Movil (AMX) Q2 Earnings Decline Y/Y, Revenues Increase - NasdaqJuly 13, 2022 | nasdaq.comMGM Resorts (MGM) Announces Partnership With MLB Players - NasdaqJuly 13, 2022 | nasdaq.comAptinyx to Participate in H.C. Wainwright 1st Annual Mental Health ConferenceJune 22, 2022 | finance.yahoo.com Get Aptinyx News Delivered to You Automatically Sign up to receive the latest news and ratings for APTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss. Click Here to get the full details about Crypto’s Hidden Gem APTX Media Mentions By Week APTX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. APTX News Sentiment▼0.000.59▲Average Medical News Sentiment APTX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. APTX Articles This Week▼00▲APTX Articles Average Week Get Aptinyx News Delivered to You Automatically Sign up to receive the latest news and ratings for APTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Pharvaris News Eli Lilly and Company News Novo Nordisk A/S News Johnson & Johnson News AbbVie News Merck & Co., Inc. News AstraZeneca News Novartis News Abbott Laboratories News Pfizer News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:APTX) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aptinyx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aptinyx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
